Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM, Hardan I, Raz H, Adamou AK, Inbar M, Gottfried M, Merrick Y, Cohen Y, Sulkes A, Ben-Baruch N, Pfeffer RP, Brenner HJ, Rizel S. Stemmer SM, et al. Among authors: adamou ak. Bone Marrow Transplant. 2003 Apr;31(8):655-61. doi: 10.1038/sj.bmt.1703856. Bone Marrow Transplant. 2003. PMID: 12692605
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
Polyzos A, Malamos N, Boukovinas I, Adamou A, Ziras N, Kalbakis K, Kakolyris S, Syrigos K, Papakotoulas P, Kouroussis C, Karvounis N, Vamvakas L, Christophyllakis C, Athanasiadis A, Varthalitis I, Georgoulias V, Mavroudis D. Polyzos A, et al. Breast Cancer Res Treat. 2010 Jan;119(1):95-104. doi: 10.1007/s10549-009-0468-0. Epub 2009 Jul 28. Breast Cancer Res Treat. 2010. PMID: 19636702 Clinical Trial.
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.
Fountzilas G, Vasilaros S, Koukouras D, Malamos N, Pectasides D, Adamou A, Nenopoulou E, Kiriakou K, Zouvani I, Katsohis K, Kappas A, Skopa C, Semoglou C, Fahantidis E, Konstantaras C, Vasilaki E, Economopoulos T, Bacoyiannis H, Bafaloukos D, Razi E, Polichronis A, Androulakis G, Papaioannou T, Pavlidis N, Kosmidis P, et al. Fountzilas G, et al. Anticancer Res. 1997 Nov-Dec;17(6D):4681-9. Anticancer Res. 1997. PMID: 9494589
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Fountzilas G, Tsavdaridis D, Kalogera-Fountzila A, Christodoulou CH, Timotheadou E, Kalofonos CH, Kosmidis P, Adamou A, Papakostas P, Gogas H, Stathopoulos G, Razis E, Bafaloukos D, Skarlos D. Fountzilas G, et al. Ann Oncol. 2001 Nov;12(11):1545-51. doi: 10.1023/a:1013184301155. Ann Oncol. 2001. PMID: 11822753 Free article. Clinical Trial.
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
Fountzilas G, Stathopoulos G, Kouvatseas G, Polychronis A, Klouvas G, Samantas E, Zamboglou N, Kyriakou K, Adamou A, Pectasidis D, Ekonomopoulos T, Kalofonos HP, Bafaloukos D, Georgoulias V, Razis E, Koukouras D, Zombolas V, Kosmidis P, Skarlos D, Pavlidis N; Hellenic Cooperative Oncology Group. Fountzilas G, et al. Am J Clin Oncol. 2004 Feb;27(1):57-67. doi: 10.1097/01.coc.0000046121.51504.b9. Am J Clin Oncol. 2004. PMID: 14758135 Clinical Trial.
15 results